These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28224023)

  • 21. Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.
    Hu WQ; Wang W; Fang DL; Yin XF
    Med Sci Monit; 2018 May; 24():3450-3461. PubMed ID: 29795057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodes.
    Singh S; Colonna G; Di Bernardo G; Bergantino F; Cammarota M; Castello G; Costantini S
    Mol Biosyst; 2015 Nov; 11(11):2933-45. PubMed ID: 26267014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 24. Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.
    Zamanian Azodi M; Arjmand B; Zali A; Razzaghi M
    Gastroenterol Hepatol Bed Bench; 2020; 13(4):367-373. PubMed ID: 33244380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningioma protein-protein interaction network.
    Zali H; Rezaei Tavirani M
    Arch Iran Med; 2014 Apr; 17(4):262-72. PubMed ID: 24724603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
    Liu CC; Wang YH; Chuang EY; Tsai MH; Chuang YH; Lin CL; Liu CJ; Hsiao BY; Lin SM; Liu LY; Yu MW
    Mol Carcinog; 2014 Jan; 53(1):58-66. PubMed ID: 22911910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
    Zhang Y; Wang S; Xiao J; Zhou H
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation.
    Ni W; Zhang S; Jiang B; Ni R; Xiao M; Lu C; Liu J; Qu L; Ni H; Zhang W; Zhou P
    Pathol Res Pract; 2019 Jun; 215(6):152428. PubMed ID: 31064721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis.
    Huang D; Yuan W; Li H; Li S; Chen Z; Yang H
    Exp Ther Med; 2018 Sep; 16(3):1850-1858. PubMed ID: 30186410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
    Liang J; Lv J; Liu Z
    Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    Gao B; Zhang X; Huang Y; Yang Z; Zhang Y; Zhang W; Gao ZH; Xue D
    PLoS One; 2017; 12(3):e0174142. PubMed ID: 28355233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and analysis of a comprehensive protein interaction network of HCV with its host Homo sapiens.
    Farooq QUA; Khan FF
    BMC Infect Dis; 2019 Apr; 19(1):367. PubMed ID: 31039741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.
    Liu J; Hua P; Hui L; Zhang LL; Hu Z; Zhu YW
    Exp Ther Med; 2016 Oct; 12(4):2109-2119. PubMed ID: 27703495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma.
    Shi SQ; Ke JJ; Xu QS; Wu WQ; Wan YY
    Neoplasma; 2018; 65(1):66-74. PubMed ID: 29322790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
    Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
    Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.
    Li N; Li L; Chen Y
    Oxid Med Cell Longev; 2018; 2018():3478305. PubMed ID: 29977454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation.
    Kotni MK; Zhao M; Wei DQ
    Orphanet J Rare Dis; 2016 Nov; 11(1):148. PubMed ID: 27814735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.